Quick Takeaways
- Unity Biotechnology, Inc. has 16 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 16 Insiders of Unity Biotechnology, Inc.
- Location
- South San Francisco, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 26 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Unity Biotechnology, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anirvan Ghosh | Chief Executive Officer, Director | $158,058 | Filing P/S | 02 Apr 2025 | ||
| Jamie Dananberg | Chief Medical Officer | $114,955 | Mixed | 31 Mar 2023 | ||
| Lynne Marie Sullivan | CFO & Head of Corp. Dev. | $101,872 | Filing P/S | 02 Apr 2025 | ||
| Alexander Hieu Nguyen | CLO and Head of Ops | $50,216 | Filing P/S | 02 Apr 2025 | ||
| Nathaniel E. David | Director | Mixed | 21 Jun 2024 | |||
| Michael P. Samar | Director | Mixed | 21 Jun 2024 | |||
| Paul L. Berns | Director | Mixed | 21 Jun 2024 | |||
| Gilmore Neil O'Neill | Director | Mixed | 21 Jun 2024 | |||
| Margo R. Roberts | Director | Mixed | 21 Jun 2024 | |||
| Kristina Burow | Director | Mixed | 24 Jun 2021 | |||
| Keith R. Leonard | Director | Mixed | 21 Jun 2024 | |||
| Camille D. Samuels | Director | Mixed | 21 Jun 2024 | |||
| Craig R. Jalbert | President and Secretary, Director | Mixed | 27 Jun 2025 | |||
| Yehia Hashad | Director | Mixed | 08 Mar 2025 | |||
| Federico Grossi | Chief Medical Officer | Mixed | 06 Jan 2025 | |||
| Graham K. Cooper | Director | Mixed | 24 Jun 2021 |
Top shareholders of Unity Biotechnology, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. |
13D/G
|
— |
9.2%
|
1,578,091
|
$1,546,529 | $0 | 31 Mar 2025 | |
| Anirvan Ghosh |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
439,454
mixed-class rows
|
$158,058 | — | 02 Apr 2025 | |
| Jamie Dananberg |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
62,817
|
$114,955 | — | 31 Mar 2023 | |
| Lynne Marie Sullivan |
3/4/5
|
CFO & Head of Corp. Dev. |
—
mixed-class rows
|
204,905
mixed-class rows
|
$101,872 | — | 02 Apr 2025 | |
| Alexander Hieu Nguyen |
3/4/5
|
CLO and Head of Ops |
—
mixed-class rows
|
121,753
mixed-class rows
|
$50,216 | — | 02 Apr 2025 | |
| Federico Grossi |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
150,000
|
— | — | 06 Jan 2025 | |
| Graham K. Cooper |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 24 Jun 2021 | |
| Kristina Burow |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 24 Jun 2021 | |
| Yehia Hashad |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 08 Mar 2025 | |
| Camille D. Samuels |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 | |
| Gilmore Neil O'Neill |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 | |
| Keith R. Leonard |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 | |
| Margo R. Roberts |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 | |
| Michael P. Samar |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 | |
| Nathaniel E. David |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 | |
| Paul L. Berns |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 21 Jun 2024 |
Recent Insider Transactions by Companies or Individuals for Unity Biotechnology, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.